# A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State

> **NCT01690351** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** PF-05089771
- **DRUG:** PF-05089771

## Key facts

- **NCT ID:** NCT01690351
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01690351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01690351, "A Study Comparing PF-05089771 TS Capsule To PF-05089771 TS Oral Dispersion In The Fasted State". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01690351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*